VivaVision Biotech
Shanghai
About VivaVision Biotech
VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases. VivaVision Biotech is dedicated to bringing new therapeutics to millions of patients suffering from chronic ocular or dermal inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $84.9M
- Funding stage: Late Stage Venture
- Last round: Series D (Jul 2025)
- Website: vivavisionbio.comenindex.php?a=lists&catid=6
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/vivavision-biotech-10680 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.